Who We Are
Mission
KrebsNeumann is dedicated to making research opportunities accessible beyond the confines of traditional academic institutions. Our mission is to empower motivated students from diverse backgrounds by involving them in real-world research across life sciences, technology, and healthcare—spanning the full spectrum of STEM. As transdisciplinary and translational scientists, we welcome students from around the globe to collaborate on active projects. Participants work alongside experienced researchers, gain hands-on experience, and are encouraged to take leadership roles, with the goal of contributing to publications in peer-reviewed journals.
.......... mentoring next generation scientists
Approach
We integrate scientific expertise with advanced technology to address some of the most pressing challenges in modern medicine. Our work is grounded in a deep commitment to clinical impact and patient-centered innovation. By bridging disciplines and applying breakthroughs in data science, diagnostics, and therapeutic development, we strive to accelerate the translation of research into real-world medical solutions. We are driven by the belief that pushing the boundaries of knowledge and embracing emerging technologies can lead to transformative advances in diagnosis, treatment, and care delivery. From early discovery to clinical application, our mission is to improve patient outcomes and shape the future of healthcare.
.......... peer-to-peer collaborations
Focus Areas
P4 Medicine
Understanding patients and the way diseases manifest is essential for advancing clinical outcomes. P4 medicine—predictive, preventive, personalized, and participatory—provides a transformative framework to achieve this goal. By anticipating disease risks, tailoring interventions to individual needs, and actively involving patients in their care, P4 medicine paves the way for more effective, efficient, and equitable healthcare.
Digital Medicine
Wearable technologies offer valuable insights into daily physiological and behavioral changes.
When integrated into a unified platform, these continuous data streams hold the potential to predict clinical events before they occur—enabling earlier interventions, improved monitoring, and more proactive healthcare.
Computational Biology
Cancer is a heterogeneous disease that demands a precise understanding of its underlying genetic mutations. Computational biology plays a pivotal role in uncovering these complexities, enabling researchers to decode molecular patterns and accelerate the development of targeted therapies. By integrating data-driven insights with biological knowledge, it lays the foundation for more effective and personalized cancer treatment strategies.
Innovation
The Bench-to-Bedside program offers a vital opportunity to understand the key steps involved in translating scientific discoveries into clinical applications. Successful innovation in medicine demands a multidisciplinary approach—combining insights from science, engineering, regulatory affairs, clinical practice, and business strategy—to move ideas from the lab to real-world patient care.
Founder
Shashaanka Ashili, PhD
-
Research profile: Peer reviewed publications: 45+, Citations: nearly 1000, h-index: 14 and i10 index: 19
​​
-
Scientist and entrepreneur working at the intersection of technology, life sciences, and healthcare—driving innovation in translational medicine.
​
-
Nearly two decades of experience as a scientist (physical and life sciences) and founder of multiple startups.
​​​
-
Dedicated to advancing personalized and preventive medicine through integrative multi-omics and data-driven solutions.
​​
-
Organizer of LongevityAsia, a symposium aimed at catalyzing advancements in Aging and Quality of Life (QoL).
​​
-
Ph.D. in Optical Science, University of North Carolina at Charlotte; Fellowship in Medical innovation, Dept of Surgery, University of Missouri, Columbia. ​​
